Aura Biosciences

About

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Cambridge,Massachusetts,United States
51 - 100
http://www.aurabiosciences.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $80.40M
Industries: Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 2007
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: nasdaq:AURA
Legal Name: Aura Biosciences, Inc.

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives of people with a wide range of cancers that are poorly managed today.

The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal.

Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

15

$357.96M

Aura Biosciences has raised a total of $357.96M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 30, 2022	Post-IPO Equity	$80.40M	—	—	—	Detail
Nov 3, 2021	Post-IPO Equity	—	1	Ysios Capital	—	Detail
Oct 29, 2021	IPO	$75.60M	—	—	—	Detail
Mar 22, 2021	Series Unknown	$80M	11	Matrix Capital Management Surveyor Capital	—	Detail
Jul 9, 2020	Series Unknown	$10M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

7

18

Aura Biosciences is funded by 18 investors. Ysios Capital and Matrix Capital Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Ysios Capital	Yes	Post-IPO Equity
Matrix Capital Management	Yes	Series Unknown
Surveyor Capital	Yes	Series Unknown
Adage Capital Management	—	Series Unknown
Advent Life Sciences	—	Series Unknown
Arix Bioscience	—	Series Unknown
Chiesi Ventures	—	Series Unknown
Columbus Venture Partners	—	Series Unknown
Lundbeckfonden Ventures	—	Series Unknown
Medicxi	—	Series Unknown